Logo image of SSNT

SILVERSUN TECHNOLOGIES INC (SSNT) Stock Fundamental Analysis

NASDAQ:SSNT - Nasdaq - US82846H2076 - Common Stock - Currency: USD

16.31  -3.3 (-16.83%)

After market: 16.5 +0.19 (+1.16%)

Fundamental Rating

3

SSNT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 283 industry peers in the Software industry. SSNT has an average financial health and profitability rating. SSNT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year SSNT has reported negative net income.
In the past year SSNT had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: SSNT reported negative net income in multiple years.
SSNT had a positive operating cash flow in 4 of the past 5 years.
SSNT Yearly Net Income VS EBIT VS OCF VS FCFSSNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M 4M 6M

1.2 Ratios

SSNT has a Return On Assets (-5.81%) which is in line with its industry peers.
SSNT has a Return On Equity of -15.94%. This is comparable to the rest of the industry: SSNT outperforms 49.28% of its industry peers.
Looking at the Return On Invested Capital, with a value of 13.65%, SSNT belongs to the top of the industry, outperforming 92.03% of the companies in the same industry.
Industry RankSector Rank
ROA -5.81%
ROE -15.94%
ROIC 13.65%
ROA(3y)-2.43%
ROA(5y)5.94%
ROE(3y)-6.24%
ROE(5y)12.03%
ROIC(3y)N/A
ROIC(5y)N/A
SSNT Yearly ROA, ROE, ROICSSNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

1.3 Margins

SSNT has a better Operating Margin (2.75%) than 68.84% of its industry peers.
In the last couple of years the Operating Margin of SSNT has grown nicely.
Looking at the Gross Margin, with a value of 39.26%, SSNT is doing worse than 77.90% of the companies in the same industry.
SSNT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.75%
PM (TTM) N/A
GM 39.26%
OM growth 3Y79.19%
OM growth 5Y25.16%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.48%
GM growth 5Y-0.8%
SSNT Yearly Profit, Operating, Gross MarginsSSNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30 40

More info and screens

5

2. Health

2.1 Basic Checks

SSNT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, SSNT has more shares outstanding
Compared to 5 years ago, SSNT has less shares outstanding
SSNT has a worse debt/assets ratio than last year.
SSNT Yearly Shares OutstandingSSNT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M
SSNT Yearly Total Debt VS Total AssetsSSNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

An Altman-Z score of 3.32 indicates that SSNT is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.32, SSNT is in line with its industry, outperforming 57.97% of the companies in the same industry.
SSNT has a debt to FCF ratio of 1.25. This is a very positive value and a sign of high solvency as it would only need 1.25 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.25, SSNT is in the better half of the industry, outperforming 71.74% of the companies in the same industry.
A Debt/Equity ratio of 0.14 indicates that SSNT is not too dependend on debt financing.
SSNT has a Debt to Equity ratio of 0.14. This is comparable to the rest of the industry: SSNT outperforms 48.55% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 1.25
Altman-Z 3.32
ROIC/WACC1.37
WACC10%
SSNT Yearly LT Debt VS Equity VS FCFSSNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M 4M 6M 8M

2.3 Liquidity

A Current Ratio of 1.05 indicates that SSNT should not have too much problems paying its short term obligations.
With a Current ratio value of 1.05, SSNT is not doing good in the industry: 74.28% of the companies in the same industry are doing better.
A Quick Ratio of 1.05 indicates that SSNT should not have too much problems paying its short term obligations.
The Quick ratio of SSNT (1.05) is worse than 73.19% of its industry peers.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 1.05
SSNT Yearly Current Assets VS Current LiabilitesSSNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for SSNT have decreased strongly by -66220640690479628288.00% in the last year.
The Revenue has grown by 18.53% in the past year. This is quite good.
The Revenue has been growing slightly by 5.86% on average over the past years.
EPS 1Y (TTM)-66220640690479630000%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%315.64%
Revenue 1Y (TTM)18.53%
Revenue growth 3Y9.77%
Revenue growth 5Y5.86%
Sales Q2Q%9.98%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SSNT Yearly Revenue VS EstimatesSSNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
SSNT Yearly EPS VS EstimatesSSNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 0.05 0.1 0.15

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

SSNT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SSNT Price Earnings VS Forward Price EarningsSSNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SSNT indicates a rather cheap valuation: SSNT is cheaper than 98.55% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, SSNT is valued cheaply inside the industry as 97.10% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7
EV/EBITDA 2.53
SSNT Per share dataSSNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SSNT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SILVERSUN TECHNOLOGIES INC

NASDAQ:SSNT (6/5/2024, 8:18:16 PM)

After market: 16.5 +0.19 (+1.16%)

16.31

-3.3 (-16.83%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-07 2024-05-07/amc
Earnings (Next)08-06 2024-08-06/amc
Inst Owners0.07%
Inst Owner Change0%
Ins Owners78.89%
Ins Owner Change0%
Market Cap10.84M
Analysts82.5
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.2
Dividend Growth(5Y)N/A
DP-86.68%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.19
P/FCF 7
P/OCF 6.27
P/B 1.42
P/tB 6.15
EV/EBITDA 2.53
EPS(TTM)-2.3
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)2.33
FCFY14.28%
OCF(TTM)2.6
OCFY15.96%
SpS84.02
BVpS11.45
TBVpS2.65
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.81%
ROE -15.94%
ROCE 17.28%
ROIC 13.65%
ROICexc 46.51%
ROICexgc N/A
OM 2.75%
PM (TTM) N/A
GM 39.26%
FCFM 2.77%
ROA(3y)-2.43%
ROA(5y)5.94%
ROE(3y)-6.24%
ROE(5y)12.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y90.48%
ROICexc growth 5Y39.11%
OM growth 3Y79.19%
OM growth 5Y25.16%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.48%
GM growth 5Y-0.8%
F-Score3
Asset Turnover2.68
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 1.25
Debt/EBITDA 0.42
Cap/Depr 17.67%
Cap/Sales 0.33%
Interest Coverage 53.51
Cash Conversion 67.48%
Profit Quality N/A
Current Ratio 1.05
Quick Ratio 1.05
Altman-Z 3.32
F-Score3
WACC10%
ROIC/WACC1.37
Cap/Depr(3y)14.01%
Cap/Depr(5y)16%
Cap/Sales(3y)0.31%
Cap/Sales(5y)0.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-66220640690479630000%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%315.64%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)18.53%
Revenue growth 3Y9.77%
Revenue growth 5Y5.86%
Sales Q2Q%9.98%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y534.44%
EBIT growth 3Y96.7%
EBIT growth 5Y32.5%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y166.87%
FCF growth 3Y-34%
FCF growth 5Y-2.67%
OCF growth 1Y140.18%
OCF growth 3Y-30.38%
OCF growth 5Y-14.66%